Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radical Surgery vs Non-Surgery in Gastric Cancer with Peritoneal Metastasis After Conversion Therapy
NCT07789184Phase 3Recruiting
- Start
- Dec 2026
- Primary completion
- Oct 2031
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gastric cancer (GC) and peritoneal metastasis (PM) (2 arms). Primary endpoint: Overall Survival up to 3 years. Planned start Dec 2026; status: recruiting.
02
Conditions
gastric cancer (GC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT07789184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07789184.